As GLP-1 weight-loss drugs like Ozempic reshape how consumers eat, food and beverage manufacturers are racing to develop ...

This systematic review and meta-analysis found that while yogurt consumption shows a modest positive association with bone ...

Researchers have developed a miniature 3D human colon model that mimics lifelike functions to enhance precision in cancer ...

Researchers have developed the world’s first flow battery powered by glucose and vitamin B2, mimicking the human body’s ...

(Head of Commercial: Mike Petroutsas, "Astellas") today announced final overall survival (OS) results from the Phase 3 EMBARK study evaluating XTANDI ® (enzalutamide), in combination with leuprolide ...

Results from the TheraPb Phase 1b dose escalation presented at ESMO 2025 show a promising therapeutic index for 212Pb-ADVC001 in patients with ...

Wellness purchases are now treated more like scientific procurement than regular shopping. Buyers look for data, authenticity ...

Watch parts 1, 2, and 3 of our conversation with Dr Collins.

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today announced that it will present new clinical data from its Phase 2 trial of EB613 at ...

Nanopore sensors enable precise protein and peptide analysis, crucial for early disease diagnosis and advancing personalized healthcare solutions.